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Summary 
Poor sleep is a significant risk factor for depression across the lifespan and sleep problems 
have been hypothesised to contribute to the onset and maintenance of depression symptoms. 
There is a bidirectional relationship between poor sleep and depression across the lifespan. 
However, sleep problems are usually not a direct target of interventions for depression. A 
range of non-pharmacological treatments can reduce sleep problems but it is unclear whether 
these interventions also reduce other depression symptoms. The aim of this review was to 
examine whether non-pharmacological interventions for sleep problems are effective in 
reducing symptoms of depression. We carried out a systematic search for randomised 
controlled trials of non-pharmacological sleep interventions that measured depression 
symptoms as an outcome. Forty-nine trials (n=5908) were included in a random effects meta-
analysis. The pooled standardised mean difference for depression symptoms after treatment 
for sleep problems was -0.45 (95% CI: -0.55,-0.36). The size of the effect on depression 
symptoms was moderated by the size of the effect on subjective sleep quality. In studies of 
participants with mental health problems, sleep interventions had a large effect on depression 
symptoms (d=-0.81, 95% CI: -1.13,-0.49). The findings indicate that non-pharmacological 
sleep interventions are effective in reducing the severity of depression, particularly in clinical 
populations. This suggests that non-pharmacological sleep interventions could be offered as a 
treatment for depression, potentially improving access to treatment.    
Keywords: depression; mood; sleep; insomnia; intervention; treatment; meta-analysis 
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Glossary 
Cognitive behavioural therapy for insomnia: A multi-component psychological intervention 
comprising a range of strategies designed to target the behavioural and cognitive 
underpinnings of insomnia.  
Forest plot: Graphical representation of the results of a meta-analysis.  
Funnel plot: Used to detect bias in trials included in a meta-analysis. Publication bias will 
result in asymmetry in the plot.   
Heterogeneity: Variability in observed effect sizes that is greater than would be expected by 
chance alone.  
Meta-regression: A statistical technique that allows the association between continuous, as 
well as categorical, study characteristics and the intervention effects observed to be 
investigated.  
Paradoxical intention: Instructing the client to stop trying to fall asleep and instead stay 
awake for as long as possible in order to lessen anxiety about falling asleep. 
Rosenthal’s failsafe N: The number of additional studies in which the intervention effect was 
zero that would need to be included in a meta-analysis to increase the P value to above 0.05. 
Sleep restriction therapy: Limiting the time spent in bed to the actual time spent sleeping in 
order to increase sleep efficiency.  
Stimulus control therapy: Providing the client with instructions designed to re-associate the 
bed/bedroom with sleep. 
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Introduction 
Depression is a common mental health problem, with a lifetime prevalence of approximately 
15% in high income countries [1]. It is among the leading causes of disability globally [2], 
but only a small minority of individuals experiencing depression receive adequate treatment 
[3].  More than 65% of adults with major depressive disorder report sleep difficulties [4,5], 
including difficulty falling asleep, frequent awakenings during the night, early morning 
awakening and non-restorative sleep [6], and around 40% report sleep disturbance severe 
enough to warrant a diagnosis of insomnia [7]. Among adolescents with depression, recent 
research indicates that up to 90% present with disturbed sleep [8,9]. In both children and 
adults, those who experience sleep problems present with more severe depression than 
depressed individuals without sleep problems [10,11].    
 
Depression has often been conceptualised as a cause of sleep problems [12], reflected in the 
inclusion of sleep disturbance in the diagnostic criteria for depressive disorders in both 
commonly used diagnostic manuals (DSM-5 [13] and ICD-10 [14]). However, sleep 
problems often predate the onset of depression [15,16], and are among the most commonly 
reported residual symptoms after the remission of a depressive disorder [17]. Thus it has been 
suggested that, rather than sleep problems being a symptom or consequence of depression, 
that depression and sleep disorders may constitute separate syndromes that co-occur as a 
result of shared causal pathways [18].  
 
Longitudinal research suggests a bidirectional relationship between depression and sleep, 
with sleep disturbances predicting later depressive episodes as well as vice versa [19]. In a 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
RUNNING HEAD: EFFECT OF NON-PHARMACOLOGICAL SLEEP INTERVENTIONS ON DEPRESSION SYMPTOMS 
5 
 
meta-analysis of longitudinal studies, the risk of non-depressed individuals with insomnia 
subsequently developing depression was found to be twice that of people without sleep 
difficulties [20]. Studies examining the prospective role of sleep in the development of 
depression have found sleep problems to be a risk factor for subsequent depression across the 
lifespan, from adolescence [21] through to older adulthood [22]. 
 
Further, there is some evidence to support the hypothesis that poor sleep might play a causal 
role in the onset and maintenance of depression symptoms [23,24]. In experimental and 
quasi-experimental studies, sleep deprivation has been found to increase negative mood [23], 
decrease positive emotional responses to goal-enhancing events [25] and bring about poorer 
memory for positively valenced words [26]. In addition, healthy adult volunteers subjected to 
six days of sleep curtailment have been found to show electroencephalography abnormalities 
and endocrine disturbances usually observed in depression [18]. In adolescents, even modest 
sleep restriction over five nights has been found to result in worsened mood, increased 
irritability and decreased ability to regulate negative emotions [27]. 
 
Given the hypothesis that poor sleep might contribute to the onset and maintenance of 
depression, it is plausible that treatments that are successful in improving sleep might also 
lead to reductions in symptoms of depression. Pharmacological sleep treatments have been 
found to produce short-lived improvements in sleep but are not recommended for longer-term 
sleep problems due to poor efficacy [28] and concerns about dependence and other adverse 
effects [29].   
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Non-pharmacological interventions are effective in improving sleep, both in individuals with 
primary insomnia [30,31], and in those with sleep problems in the context of medical and 
psychiatric disorders [32–34]. Insomnia is the most common sleep complaint, both in 
individuals with depression [5,11] and in the general population [34]. A range of non-
pharmacological psychological interventions have been found to be effective treatments for 
insomnia, including stimulus control therapy, relaxation training, sleep restriction therapy, 
biofeedback, paradoxical intention and multicomponent cognitive behavioural therapy for 
insomnia (CBT-I) [35].  
 
Depression symptoms are often measured as a secondary outcome in trials of non-
pharmacological interventions designed to improve sleep. A number of previous reviews 
have included analyses of the effect of interventions targeting sleep problems on depression 
symptoms. The results of previous meta-analyses suggest that both internet-delivered [36] 
and group-based [37] CBT-I have small but significant effects on depression symptoms, 
despite these symptoms not being specifically targeted.  
 
However, a recent network meta-analysis of behavioural and cognitive behavioural 
interventions for adults with insomnia [38] found that only individual, face-to-face CBT-I 
had a significant effect on depression symptoms when compared to a placebo condition. 
Studies were included in this analysis if the trial intervention incorporated sleep restriction, 
and depression was measured using a standardised measure. The authors grouped the CBT-I 
interventions trialled into six classes according to their treatment components and delivery 
mode, and compared each class of intervention to placebo conditions (pills or behavioural 
placebo). Significant moderate-sized mean effects were found for individual CBT-I, but no 
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significant effects were found for other treatment classes. However, tThe conclusions that 
could be drawn from this analysis were limited by significant heterogeneity that was not 
explained by the clinical, demographic or methodological characteristics examined, which 
included age, sex, whether participants with comorbidities were excluded, and risk of bias. 
 
One possible source of heterogeneity in the effect of sleep interventions on depression is 
variation in the size of effect on the sleep symptoms directly targeted. The authors of a recent 
review of CBT-I for insomnia in adults with co-morbid major depressive disorder [39] 
suggest that improvement in depression following CBT-I for insomnia may be mediated by 
improvement in insomnia symptoms. While tThere are plausible mechanisms through which 
improvements in sleep might lead to improvements in depression symptoms. These include 
the impact of improved sleep on quality of life, emotion regulation and cognitive functioning 
[40,41], as well as reductions in neurobiological abnormalities common to both mood and 
sleep disturbances [42]. However, there are also a range of non-specific factors that might 
account for the effect of sleep-interventions on depression, for instance increased motivation 
or hope as a result of developing a therapeutic relationship or participation in a therapeutic 
process [43]. As such, the extent to which improvements in depression symptoms are 
accounted for by improved sleep warrants investigation. 
 
The aim of the current review was to identify and synthesise the results of all randomised 
controlled trials of non-pharmacological interventions designed to improve sleep that 
reported depression symptoms as an outcome. Eligible interventions were designed to 
improve the amount, quality or timing of sleep, including but not limited to interventions for 
insomnia. The review was not restricted to a particular intervention or client group, and the 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
RUNNING HEAD: EFFECT OF NON-PHARMACOLOGICAL SLEEP INTERVENTIONS ON DEPRESSION SYMPTOMS 
8 
 
impact of the age of trial participants and presence or absence of mental health comorbidities 
was examined.  
 
A secondary goal was to examine whether improvements in symptoms of depression were 
moderated by improvements in subjective sleep quality in order to assess whether 
heterogeneity in the effect of sleep interventions on depression can be explained by variation 
in how effective the intervention is in improving perceived sleep quality likely mechanisms 
of action. Better understanding the impact of non-pharmacological sleep interventions on 
depression symptoms will be important in enabling us to assess in which cases interventions 
targeting sleep might be appropriately harnessed as treatment options for depression. 
 
Methods 
Search strategy 
The review was conducted in accordance with guidance in the ‘preferred reporting items for 
systematic reviews and meta-analyses’ (PRISMA) statement [44]. The protocol was 
registered with the PROSPERO registry prior to implementation of the search strategy and 
can be accessed at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42017054940. 
 
The search strategy aimed to identify all eligible trials reported in the English language in a 
peer-reviewed journal.  Four electronic databases, PsycINFO, Medline, CINAHL and 
CENTRAL, were searched from their inception until 1st May 2018. The following search 
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terms were used: (sleep OR insomnia OR “sleep treatment” OR “sleep disorders”) AND 
(intervention OR treatment OR therapy OR help OR hygiene OR support OR education) 
AND (depressi* OR mood). Limiters were used to narrow the search to clinical trials and 
English language publications. We also hand searched the reference lists of eligible articles 
and key review papers to identify any eligible articles missed by the electronic search.  
 
Eligibility Criteria 
The inclusion criteria employed were as follows: (1) randomised controlled trial; (2) trial 
intervention was a non-pharmacological intervention specifically designed to improve sleep 
(amount, quality or timing); (3) trial included a control condition not designed to improve 
sleep; (4) depression symptoms were measured (as either a primary or secondary outcome) 
using a validated instrument; (5) the trial was reported in the English language in a peer 
reviewed journal. Studies that met any of the following criteria were excluded: (1) the trial 
intervention included a pharmacological component (including traditional/herbal remedies); 
(2) all trial arms received an intervention designed to improve sleep (for instance, the only 
control condition was a pharmacological sleep aid or sleep hygiene); (3) trial intervention 
was designed to treat parasomnias, sleep apnoea or fatigue (as these are thought to have 
causal factors distinct from other sleep problems).  
 
Study selection 
The titles and abstracts of all retrieved articles were screened by one reviewer (BG). A 
subsample of 10% of articles (selected using a random number generator) was screened 
independently by a second reviewer (AJ) to check that no potentially eligible articles were 
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excluded. The full texts of all articles deemed potentially relevant were obtained and assessed 
for eligibility against the inclusion/exclusion criteria by two reviewers independently (BG 
and one of FO, EC, AJ, TC or SR). All disagreements regarding eligibility were discussed by 
the two reviewers and, if consensus not reached, resolved by a third reviewer. Where multiple 
publications describing the same trial were identified, only the article reporting on the larger 
sample was included.  
 
Data extraction and quality assessment 
Data were extracted independently by two reviewers (BG and EC) and cross-checked to 
ensure accuracy. The following information was recorded using a customised data extraction 
spreadsheet: study characteristics (authors, title, year of publication), intervention type, age of 
sample, psychiatric comorbidities, depression measure used, subjective sleep quality measure 
used, size of intervention and control groups, baseline and outcome data (at first time-point 
post-intervention) for depression and sleep quality (means and standard deviations). Where 
insufficient outcome data were reported for the study to be included in the meta-analysis, we 
contacted corresponding authors to request this data. The methodological quality of included 
studies was assessed by one reviewer (AJ) using the Cochrane collaboration’s risk of bias 
tool [45]. For a random subsample of 10% of included studies, the risk of bias assessment 
was independently verified by a second reviewer (BG) and discrepancies resolved through 
discussion. 
 
Data synthesis 
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All eligible studies for which sufficient data on depression outcomes were reported or could 
be obtained from the corresponding author were included in a random effects meta-analysis. 
Review Manager Version 5.3 [46] was used to perform the meta-analysis. Standardised mean 
differences of depression scores at post-intervention and their 95% confidence intervals were 
calculated for each study, and weighted according to sample size via the random effects 
model. Standardised mean differences greater than 0.8 were considered large, 0.5 moderate 
and 0.2 small [47].  
 
Where more than one non-pharmacological intervention designed to improve sleep was 
included in the trial, data for the most intensive intervention (determined by consensus of two 
reviewers) was included in the meta-analysis. The most intensive intervention was 
determined by consensus of two reviewers based on the amount of face-to-face contact the 
intervention included (so that interventions delivered in a self-help format were classed as 
less intensive than therapist-delivered interventions). A random effects model was selected as 
we expected there would be heterogeneity in study effect sizes because of diversity in their 
target populations and the specific interventions trialled. Statistical heterogeneity was 
assessed using the Chi2 and I2 statistics. Significant heterogeneity is indicated by a Chi2 
statistic greater than the degrees of freedom and a p value<0.05; I2 values range from 0% to 
100%, with higher values indicating greater heterogeneity [48]. Publication bias was assessed 
via construction and visual inspection of a funnel plot and by calculating Rosenthal’s failsafe 
N.  
 
Two planned subgroup analyses were carried out to investigate sources of heterogeneity. The 
first divided the studies into those that recruited from populations who had sleep problems in 
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the context of mental health problems and those that recruited from populations without 
clinical mental health problems. Studies were classified as recruiting from a population with 
mental health problems if all participants either (a) meet standardised diagnostic criteria for at 
least one functional mental disorder (determined via chart review or diagnostic interview) or 
(b) scored above the clinical threshold on a validated measure of mental health 
symptomatology. The second planned subgroup analysis divided the studies according to the 
age range of participants: children/adolescents (aged up to 19), adults (aged 18+), older adults 
(aged 50+). Additionally, a post-hoc subgroup analysis was conducted to investigate the 
impact of the depression measure employed on the effect size detected. Only trials that 
measured depression using an instrument employed by at least two other trials were included 
in this analysis.  
 
Finally, a random effects meta-regression was carried out to assess whether the effect of an 
intervention on depression symptoms was predicted by its effect on subjective sleep quality. 
This was achieved by calculating effect sizes (standardised mean difference) for all studies 
that reported subjective sleep quality post-intervention and entering these as covariates in a 
meta-regression using Field and Gillett’s SPSS syntax files [49].       
 
Results 
Study selection 
The study selection process is illustrated in Figure 1. Sixty-one papers were identified that 
met the inclusion criteria, however three were secondary analyses of already included trials 
and we were unable to obtain sufficient depression data for inclusion in the meta-analysis 
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from the published report or by contacting the corresponding author for nine studies. 
Therefore data from 49 articles are included in the meta-analysis.  
[Inset Figure 1] 
 
Characteristics of included studies 
Characteristics of the 49 trials included in the meta-analysis are summarised in Table 1. The 
meta-analysis included data on 5908 participants, of whom 2731 were randomised to receive 
the trial sleep intervention. The included trials were all of psychological interventions. The 
majority (39 out of 48 studies) were described by the study authors as CBT-I cognitive 
behavioural therapy (CBT) or CBT-informed interventions. Sixteen studies trialled 
interventions delivered in a self-help format, online or via a mobile application. The 
remaining trials were of face-to-face interventions, 27 delivered individually and five 
delivered in a group format. Control conditions included active interventions not specifically 
targeting sleep (e.g. dietary advice, exercise programmes), and passive controls, such as 
medical treatment as usual and waitlist.  
 
Most participants were adults; only four studies included young people aged under 18 
(n=292) and none included children under 11 years. Many of the studies recruited participants 
with physical health problems (e.g. chronic pain, heart failure, cancer), for whom sleep was a 
secondary or additional problem. Twenty studies recruited participants with primary sleep 
problems and no other comorbidity. Half of the included studies excluded participants 
deemed to have clinical levels of depression symptoms (defined either as meeting diagnostic 
criteria for a depressive disorder or scoring above a specified cut-off on a measure of 
depression symptoms). A wide range of measures of depression symptoms were used and 
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included widely used self-report questionnaires, as well as observer rating scales (e.g. the 
Hamilton rating scale for depression). Subjective sleep quality (including self-reported 
insomnia severity) was measured by 43 of the 49 included studies. The trials were conducted 
in high and upper-middle income countries across four continents (Europe, North America, 
Asia and Australasia). 
[Insert Table 1] 
 
Risk of bias 
The Cochrane collaboration’s risk of bias tool was used to assess the quality of the included 
studies and a risk of bias summary graph produced (Figure 2). The majority of studies were 
judged to be of high quality, though few studies were able to blind participants and research 
personnel, and most papers included insufficient information to be able to determine the risk 
of bias due to poor allocation concealment or selective reporting. The measures of depression 
used in the studies had sound psychometric properties, and where young people under 18 
were included, had been validated for use with adolescents. 
[Insert Figure 2] 
 
Meta-analysis of effect on depression symptoms at post-treatment 
The results of the random effects meta-analysis are illustrated in Figure 3. There was a small 
to moderate effect of non-pharmacological sleep interventions in reducing depression 
symptoms in comparison to control conditions not designed to improve sleep (standardised 
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mean difference = -0.45, 95% CI -0.55, -0.36, p<0.001, k=49).  The statistical heterogeneity 
in effect sizes among studies was moderate (I2=56%, χ2=108.8, df=48, p<0.001).  
[Inset Figure 3] 
 
Subgroup analyses and meta-regression 
Comorbid mental health difficulties 
Seven of the included studies recruited from participants with clinical mental health problems 
(typically anxiety, depression and PTSD) in addition to sleep difficulties. The subgroup 
analyses showed that the pooled effect on depression symptoms for these seven studies was 
large (standardised mean difference = -0.81, 95% CI -1.13, -0.49, p<0.001, k=7) and the 
statistical heterogeneity among these studies was small (I2=27%, χ2=8.19, df=6, p=0.22). In 
comparison, the subgroup of studies that recruited participants without clinical mental health 
difficulties (k=42) found a small effect on depression symptoms (standardised mean 
difference = -0.41, 95% CI -0.51, -0.31, p<0.001) and these effect sizes were more 
heterogeneous (I2=56%, χ2=93.45, df=41, p<0.001). 
 
Adolescents, adults and older adults 
The majority of included studies recruited adults of all ages. Four of the studies recruited 
adolescents (all participants under the age of 20) and three recruited only adults over the age 
of 50. The four trials in adolescents had the smallest pooled effect on depression symptoms 
(standardised mean difference = -0.27, 95% CI -0.50, -0.04, p=0.02, k=4), with no statistical 
heterogeneity (I2=0%, χ2=1.99, df=3, p=0.57). The pooled effect on depression symptoms for 
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the studies with adult participants was small to moderate (standardised mean difference = -
0.46, 95% CI -0.57, -0.36, p<0.001, k=42) with moderate heterogeneity (I2=59%, χ2=100.75, 
df=41, p<0.001). The three studies that recruited adults over the age of 50 had the largest 
pooled effect size but wide confidence intervals (standardised mean difference = -0.60, 95% 
CI -1.12, -0.08, p=0.02, k=3) and moderate heterogeneity (I2=47%, χ2=3.76, df=2, p=0.15). 
 
Depression measure 
The centre for epidemiological studies depression scale (CESD) was the most commonly 
used depression measure in the included studies (k=11), followed by the Beck depression 
inventory (BDI) (k=10), hospital anxiety and depression scale (HADS) (k=8), nine item 
patient health questionnaire (PHQ-9) (k=4) and the Beck depression inventory version II 
(BDI-II) (k=3). All other measures were employed in less than three of the included trials. 
The standardised mean difference was largest for trials that measured depression using the 
PHQ-9 (-0.70, 95% CI -1.00, -0.41, p<0.001), followed by the BDI (-0.56, 95% CI -0.76, -
0.36, p<0.001), the CESD (-0.45 95% CIs -0.67, -0.24, p<0.001), and the HADS (-0.34, 95% 
CIs -0.57, -0.11, p=0.003). It was smallest in trials that used the BDI-II (-0.12, 95% CIs -
0.36, 0.13, p=0.34).  
 
Effect on subjective sleep quality  
The standardised mean difference for subjective sleep quality at post-intervention could be 
calculated in the case of 40 of the 49 included studies. There was a positive linear 
relationship between the standardised mean difference of the sleep interventions on 
depression symptoms and the standardised mean difference for subjective sleep quality. The 
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meta-regression revealed that the size of the effect on subjective sleep quality was a 
significant continuous moderator of the effect on depression symptoms (β=0.447, 95% CI 
0.29, 0.60, p<0.001). The residual variation was non-significant (χ2=41.89, p=0.306) 
suggesting the statistical heterogeneity in the size of the effect of the studied sleep 
interventions on depression symptoms can be explained by variation in their effect on 
subjective sleep quality.  
 
Publication bias 
Inspection of the funnel plot (Figure 4) suggestsed that effect sizes might be slightly inflated 
in some smaller studies, with one small study a notable outlier. However, this might be 
explained by clinical diversity among the populations studied since trials that recruited 
participants with sleep problems in the context of mental health problems tended to find 
larger effect sizes and to have smaller samples than the studies that recruited participants 
without clinical mental health problems. Rosenthal’s failsafe N was 3593.46, indicating that 
3593 studies with zero effect sizes would be needed to nullify the pooled effect.    
[Insert Figure 4] 
 
Discussion 
We reviewed the evidence of the effect of non-pharmacological interventions designed to 
improve sleep on the severity of depression symptoms. The meta-analysis showed that non-
pharmacological sleep interventions reduce the severity of depression symptoms immediately 
post-intervention, and this finding was robust to the possibility of publication bias. The 
pooled effect on depression severity was in the small to moderate range. This is comparable 
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to the effect size of targeted non-pharmacological psychological interventions for depression 
delivered in primary care [50,51] and to non-pharmacological psychological interventions for 
depression that is comorbid with physical health problems [52–54]. The effect is, however, 
somewhat smaller than the effect sizes of non-pharmacological psychological interventions 
for depression delivered to individuals with major depression disorder [55].  
 
As would be expected given that most eligible trials were of CBT-I, or CBT-informed 
interventions for insomnia, the effect on depression symptoms we identified is comparable to 
the effects on depression symptoms reported in previous meta-analyses of CBT-I for 
insomnia [36–38]. The size of reduction in depression symptoms is also similar to the effect 
on anxiety symptoms in a meta-analysis of CBT-I for insomnia trials [56], suggesting that 
non-pharmacological sleep interventions are similarly effective in reducing both depression 
and anxiety.   
 
Whilst the pooled effect of non-pharmacological sleep interventions on depression symptoms 
is small to moderate, there was considerable heterogeneity in the size of effects observed. 
This heterogeneity is in line with previous research [38] and unsurprising given the variation 
in the participants recruited and the type of interventions trialled by the included studies. For 
participants with mental health problems, sleep interventions had a large effect on symptoms 
of depression. Such interventions have previously been found to have large effects on sleep 
symptoms in individuals with mental health problems [57]. Therefore, sleep interventions 
might be of particular benefit to this group.  
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The pooled effect size for studies that recruited children and adolescents was small compared 
to the effect sizes for those studies that recruited adults and older adults. These relatively 
modest effects on depression symptoms are in line with the small effect sizes that have been 
found in studies of non-pharmacological therapies directly targeting depression in children 
and young people [58,59]. However, none of the studies included in this review investigated 
the effect of non-pharmacological sleep interventions on children or adolescents with clinical 
level mental health difficulties, including depression, for whom sleep difficulties are both 
common and distressing [8,9]. Given the effect of sleep interventions on depression 
symptoms was larger in studies that recruited participants with sleep problems in the context 
of mental health problems, the small effect on depression in studies of children and 
adolescents might be partially accounted for by the lack of trials including young people with 
clinical-level mental health problems.  Therefore, the potential effects of sleep interventions 
for depressed children and adolescents warrants further evaluation. 
 
There was a strong association between the change in subjective sleep quality brought about 
by an intervention and its effect on depression symptoms. The statistical heterogeneity in the 
effect sizes for depression symptoms was nullified by the introduction of the effect size for 
subjective sleep quality as a covariate in the random effects meta-regression, indicating that 
the heterogeneity on the effect of the interventions on depression can be explained by 
heterogeneity in their effect on subjective sleep quality. This might support the contention 
that changes in the severity of depression symptoms were brought about by changes in 
subjective sleep quality.  
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However, it is also possible that the observed relationship between effects on depression 
symptoms and subjective sleep quality is a consequence of non-specific features of the 
intervention or study context impacting on both sleep and depression symptoms 
independently. Further research is needed to fully understand the nature of the relationship 
between the effect of sleep interventions on sleep and their effect on depression. Studies 
incorporating objective measurement of sleep variables in addition to self-reported sleep 
quality would potentially be informative. 
 
Clinical implications 
Currently, only a small minority of individuals experiencing depression receive adequate 
treatment [3].  The stigma associated with mental health problems has been identified as an 
important barrier to help-seeking and treatment adherence [60]. The effectiveness of non-
pharmacological sleep interventions on depression symptoms suggests that the use of non-
pharmacological interventions that target sleep (and not mental health difficulties) may offer 
a relatively low stigma means of reducing depression symptoms in individuals who have both 
sleep and mental health difficulties. Offering sleep interventions as a treatment option for 
those who report depression symptoms might also be particularly useful for individuals 
reluctant to engage in a targeted treatment for depression.  
 
Non-pharmacological sleep interventions can be successfully delivered in a variety of 
relatively low-cost formats [28], therefore providing these as a treatment option for people 
with depression has the potential to be cost-effective. However, caution should be exercised 
in offering non-pharmacological sleep interventions as a standalone intervention for 
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depression symptoms; residual depression symptoms should be monitored and additional 
interventions offered as necessary.  
 
Limitations 
A limitation of the current review is that, because diagnostic criteria for depression include 
sleep problems as a symptom, measures of depression typically incorporate one or more 
items assessing sleep symptoms. Since these items account for only a small proportion of the 
total scale score, it is unlikely that changes on these items alone after treatment for sleep 
problems could account for the size of the effects observed. However, lack of item level data 
meant that it was not possible to isolate the effect of the interventions trialled on non-sleep 
depression symptoms. Future trials should use depression measures that do not include items 
assessing sleep symptoms or report item-level data to enable the effect of sleep interventions 
on non-sleep depression symptoms to be investigated.  
 
A further consideration in interpreting the results of this meta-analysis is that many studies 
excluded people who reported elevated symptoms of depression or a history of major 
depression. Thus, while we cannot be certain what effect this had on the pooled effect size, it 
is possible that relatively low levels of depression before treatment for sleep problems 
reduced the overall effect of treatment on depression symptoms. We were also unable to 
assess whether participants in the included trials were offered treatment for depression or 
provided with mood management techniques before or after their participation in the sleep 
interventions trialled as this was not consistently reported. 
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The meta-analysis only included trials that reported adequate data on depression symptoms at 
post-treatment. We could not include nine trials identified as eligible for inclusion in the 
meta-analysis as we were unable to obtain sufficient data on depression outcome to calculate 
the standardised mean difference. Also, we focused on outcomes immediately post-
intervention so are unable to comment on the longevity of the effects on depression observed. 
Further, we only included trials that measured depression symptoms as an outcome. It is 
possible that trials of non-pharmacological sleep interventions that did not measure 
depression symptoms as an outcome might have differed from those that did in some fashion 
that would impact the size of the effect obtained.  
 
Conclusions 
Non-pharmacological interventions designed to improve sleep have a positive impact on 
depression symptoms. The size of the effect on depression is moderated by the effect on 
subjective sleep quality and is largest for participants experiencing sleep problems in the 
context of mental health difficulties. Further research investigating the mechanisms by which 
sleep interventions impact depression symptoms is warranted. 
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Practice points 
1. Available randomised controlled trial evidence indicates that non-pharmacological 
interventions designed to improve sleep have a small to moderate effect on depression 
symptoms when these are measured as a secondary outcome.  
2. The size of the effect on depression symptoms is moderated by the effect of the 
intervention on subjective sleep quality.  
3. The effect on depression symptoms appears to be larger in adult than in children and 
adolescents but this may be an artefact of the participants who were recruited.  
4. We found evidence of a large effect for studies that recruited participants experiencing 
sleep problems in the context of mental health difficulties. Offering non-
pharmacological sleep interventions to users of mental health services who are 
experiencing concomitant mood and sleep problems may lead to significant 
improvements in depression symptoms as well as sleep quality.     
Research agenda 
1. Future trials of sleep interventions should measure depression symptoms as an 
outcome and report this data at item level where the depression instrument used 
includes an item(s) assessing sleep problems. 
2. Future studies should investigate the mechanisms through which sleep interventions 
lead to improvements in depression symptoms. 
3. The effect of sleep interventions on depression in children and adolescents with 
mental health problems should be trialled. 
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Tables 
Table 1. Characteristics of studies included in the meta-analysis 
Study County Participants Intervention Depression 
measure 
Sleep 
measure 
Blake et al. 2016 [61] Australia Adolescents (aged 12–17) with 
high anxiety and sleep difficulties 
CBT/mindfulness-based 
group sleep intervention 
CESD PSQI 
Casault et al. 2015 [62] Canada Adults diagnosed with cancer 
with comorbid insomnia  
Self-help CBT-I with 
telephone support 
HADS ISI 
Chang et al. 2016 [63] Taiwan Adults with heart failure Educational supportive care 
programme  
HADS PSQI 
Christensen et al. 2016 [64] Australia Adult internet users with insomnia 
and subclinical depression  
Online insomnia self-help 
programme 
PHQ-9 ISI 
Currie et al. 2000 [65] Canada Adults with insomnia secondary 
to chronic pain 
Group CBT-I BDI PSQI 
Currie et al. 2004 [66] Canada Adult recovering alcoholics with 
insomnia 
Brief CBT-based insomnia 
programme 
BDI PSQI 
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Dewald-Kaufmann et al. 
2014 [67] 
Netherlands Adolescents (aged 12-19) with 
chronic sleep reduction 
Gradual sleep extension and 
sleep hygiene advice 
CDI CSRQ 
Ebert et al. 2015 [68] Germany Adult teachers with sleeping 
problems 
Online CBT-I based recovery 
training programme 
CESD PSQI 
Edinger et al. 2001 [69] USA Adults with chronic primary 
sleep-maintenance insomnia 
Individual CBT-I BDI ISQ 
Edinger et al. 2007 [70] USA Adults with primary sleep-
maintenance insomnia 
Individual CBT-I BDI ISQ 
Freeman et al. 2017 [71] UK Adult university students with 
insomnia 
Online CBT-I delivered via a 
media-rich web application 
PHQ-9 ISI 
Galovski et al. 2016 [72] USA Adult female interpersonal assault 
survivors with sleep impairment 
Sleep-directed hypnosis BDI-II PSQI 
Gradisar et al. 2011 [73] Australia Adolescents (aged 11-18) 
diagnosed with delayed sleep 
phase disorder 
Individual CBT plus morning 
bright light  
MFQ None 
Ho et al. 2014 [74] China Adult internet users with insomnia Online self-help CBT-I with HADS PSQI 
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telephone support 
Horsch et al. 2017 [75]  Netherlands Adult with insomnia and an 
Android mobile phone 
CBT-I delivered via an 
automated mobile phone app 
CESD PSQI 
Hou et al. 2014 [76] China Adults with end stage renal 
disease and comorbid insomnia 
Individual CBT-I SCL-90 PSQI 
Irwin et al. 2017 [77] USA Adult survivors of breast cancer 
with insomnia 
Group CBT-I IDS-C PSQI 
Jungquist et al. 2010 [78] UK Adults with insomnia comorbid 
with chronic pain 
Individual CBT-I BDI ISI 
Kapella et al. 2011 [79] USA Adults with insomnia and chronic 
obstructive pulmonary disease 
Individual CBT-I POMS-D PSQI 
Lancee et al. 2012 [80] Netherlands Adult internet users with insomnia Online self-help CBT-I 
 
CESD SLEEP-50 
Lancee et al. 2015 [81] Netherlands Adult internet users with insomnia Online self-help CBT-I 
 
CESD ISI 
Lancee et al. 2016 [82] Netherlands Adult internet users with insomnia Online guided CBT-I CESD ISI 
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Lancee et al. 2017 [83] Netherlands Adult internet users with insomnia 
 
Attentional bias modification 
training 
CESD ISI 
Lichstein et al. 2000 [84] USA Older adults (aged 58+) with 
insomnia secondary to illness 
Sleep hygiene, stimulus control 
and relaxation 
GDS None 
Margolies et al. 2013 [85] USA Adult veterans with PTSD and 
sleep disturbance 
CBT-I combined with imagery 
rehearsal therapy 
PHQ-9 PSQI 
McCurry et al. 1998 [86] USA Older adult (aged 50+) dementia 
caregivers with sleep problems 
Group educational and 
behavioural intervention 
CESD PSQI 
McCurry et al. 2012 [87] USA Older adults with dementia 
resident in small care homes 
Sleep education for care-staff CSDD None 
Mimeault & Morin 1999 
[88] 
Canada Adults with primary insomnia Self-help CBT-I with 
telephone support 
BDI PSQI 
Morin et al. 2005 [89] Canada Adults with insomnia symptoms 
 
Self-help CBT-I BDI-II PSQI 
Moseley et al. 2009 [90] Australia Adolescent high school students CBT-I-based classroom sleep DASS-21  None 
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(aged 15/16) education programme 
Nguyen et al. 2017 [91] Australia Adults with traumatic brain injury 
and sleep/fatigue complaints 
Individual CBT-I adapted for 
traumatic brain injury 
HADS PSQI 
Pigeon et al. 2012 [92] USA Adults with co-occurring chronic 
pain and chronic insomnia 
CBT for insomnia and pain CESD ISI 
Riedel et al. 1998 [93] USA Adults with insomnia 
 
Individual stimulus control 
sessions 
BDI None 
Rios Romenets et al. 2013 
[94] 
Canada Adults with Parkinson’s disease 
and insomnia 
Sleep hygiene training, CBT-I  
and bright light therapy 
BDI ISI 
Ritterband et al. 2012 [95] USA Adult internet users in remission 
from cancer with secondary 
insomnia 
Online CBT-I HADS ISI 
Savard et al. 2005 [96] Canada Adult women with insomnia 
secondary to breast cancer 
Group CBT-I HADS ISI 
Savard et al. 2014 [97] Canada Adult women with breast cancer 
and insomnia symptoms who 
Individual CBT-I HADS ISI 
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received radiation therapy  
Stremler et al. 2013 [98] Canada Adult women  who had recently 
given birth for the first time 
Sleep education and advice EPDS GSDS 
Suzuki et al. 2008 [99] Japan Adult workers with a desire to 
improve their sleep quality 
Online CBT-based self-help 
programme 
K6 PSQI 
Swift et al. 2012 [100] UK Adults who responded to a flyer 
advertising sleep workshops 
One-day CBT-I workshop BDI ISI 
Talbot et al. 2014 [101] USA Adults with PTSD and insomnia 
 
Individual CBT-I BDI ISI 
Tang et al. 2012 [102] UK Adults with chronic pain and 
insomnia 
Individual hybrid CBT for 
insomnia and chronic pain 
HADS ISI 
Taylor et al. 2014 [103] USA Adult college students with 
insomnia 
 
Individual CBT-I QIDS PSQI 
Thorndike et al. 2013 [104] USA Adult internet users with insomnia 
 
Online self-help CBT-I BDI-II ISI 
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Ulmer et al. 2011 [105] USA Adult veterans meeting criteria for 
PTSD and insomnia  
Sleep intervention for PTSD 
(CBT and imagery rehearsal 
therapy) 
PHQ-2 PSQI 
van Straten et al. 2009 
[106] 
Netherlands Adults with insomnia symptoms Self-help CBT-  delivered via a 
book and television 
CESD SEF 
van Straten et al. 2014 
[107] 
Netherlands Adults with insomnia Online CBT-I with support of 
online coach 
CESD PSQI 
Wagley et al. 2013 [108] USA Adult psychiatric outpatients with 
low sleep quality and depression 
symptoms 
Two session individual CBT-I PHQ-9 PSQI 
Watanabe et al. 2011 [109] Japan Adult psychiatric outpatients with 
depression and insomnia 
Individual CBT-I HDRS PSQI 
Abbreviations. BDI = Beck depression inventory; CBT-I = cognitive behavioural therapy for insomnia; CDI = children’s depression inventory; 
CESD = centre for epidemiological studies depression scale; CSDD = Cornell Scale for Depression in Dementia; CSRQ = chronic sleep 
reduction questionnaire; DASS = depression anxiety stress scale; GDS = geriatric depression scale; GSDS = general sleep disturbance scale; 
HADS = hospital anxiety and depression scale (depression subscale); HDRS = Hamilton depression rating scale; ISI = insomnia severity index; 
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K6 = Kessler psychological distress scale; MFQ = mood and feeling questionnaire; PHQ = patient health questionnaire; POMS-D = profile of 
mood states depression subscale; PSQI = Pittsburgh sleep quality inventory; SCI = sleep condition indicator; SCL-90 = symptom checklist 
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Figure Legends 
Figure 1. Flow diagram of study selection process 
Figure 2. Risk of bias graph 
Figure 3. Forrest plot for meta-analysis of the effect of non-pharmacological sleep 
interventions on depression symptoms.  
Figure 4. Funnel plot of study effect sizes (standardised mean difference) against their 
standard errors 
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